(IN BRIEF) A moderate percentage of small and medium-sized enterprises (SMEs) in Germany own patents or trademark rights, with 9% holding trademarks and 3% owning patents. Patents are more common in larger, R&D-focused, or internationally operating companies, while trademarks … Read the full press release
Posted in Banks, Business, Financial, Germany, Industrial, Small Business, Transportation & Logistics, United Kingdom
Tagged brand reputation, credit collateral, Dr. Dirk Schumacher, European countries, financing, Germany, intangible assets, international markets, KfW, loan collateral, Patents, R&D, small businesses, SME financing, SMEs, trademarks
(IN BRIEF) Pearson has promoted Sharon Hague to President of its English Language Learning (ELL) division, effective 3 March. Hague, a 25-year veteran of Pearson, will oversee the company’s expansion into key global markets and lead the development of AI-driven … Read the full press release
Posted in Business, Education, Internet & Online, Management, News, United Kingdom
Tagged AI-powered products, career growth, digital transformation, educator, ELL division, English language assessments, English Language Learning, Gio Giovannelli, global teams, international markets, Joint Council for Qualifications, K-12 assessments, Lifelong Learning, lifelong learning opportunities, Omar Abbosh, Operational Efficiency, Oxford, Pearson, Pearson’s UK Publishing Association, professional and personal benefits, sales growth, school qualifications, Sharon Hague, teaching background
(IN BRIEF) AstraZeneca’s Calquence (acalabrutinib) has been approved by the U.S. FDA for the first-line treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation. The approval is based on … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged acalabrutinib, AstraZeneca, autologous hematopoietic stem cell transplantation, bendamustine, blood cancers, Bruton’s tyrosine kinase, BTK inhibitor, Calquence, chemoimmunotherapy, COVID-19, Dave Fredrickson, ECHO Phase III trial, FDA, global regulatory review, international markets, Lymphoma Research Foundation, mantle cell lymphoma, MCL, Meghan Gutierrez, Michael Wang, oncology, PFS, progression-free survival, Project Orbis, regulatory submission, rituximab, safety profile, U.S. approval
(IN BRIEF) Story House Egmont has renewed its 75-year partnership with The Walt Disney Company to continue publishing Disney franchise magazines in 27 countries across Europe and select international markets. Beginning in 2025, Story House Egmont will also return as … Read the full press release
Posted in Business, Denmark, Entertainment, Financial, Government, Industrial, Investment, Management, Media, News, United Kingdom
Tagged age-appropriate content, Cécile Legenne, Disney franchise magazines, Disney Publishing and Games EMEA, Donald Duck magazine, Egmont media group, Europe, international markets, kids, Marika Bark, marketing teams, partnership, publishing rights, sales, Scandinavia, Story House Egmont, The Walt Disney Company, UK
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?